MAPK8 and familial pancreatic carcinoma: We show that human MUC4 and ErbB2 do physically interact in pancreatic cancer cells and that inhibition of expression of each membrane partners does not impair the same signalling pathways (inhibition of MUC4 expression affects the JNK pathway whereas that of ErbB2 alters the MAPK pathway).